Dehydrolactone (middle panel) in a polypeptide undergoes an intermolecular rearrangement to generate a ketide with a new carbon-carbon bond in the backbone. The researchers installed dehydrolactone in ...

GLP-1 receptor agonists are transforming obesity treatment, but manufacturing challenges must be addressed to meet rising ...

Paula’s Choice is the latest brand to add to the hype with its newest launch, the Pro-Collagen Peptide Plumping Moisturizer, ...

A's fiscal first-quarter performance is likely to have been influenced by higher expenses, increased CapEx and the Lunar New Year timing shift.

In a bid to break into the CDMO business at one of its most lucrative angles, India's Granules is snapping up Swiss contract ...

Brown Regular,sans-serif;font-size:.9rem;font-weight:300;line-height:1.3em;color:#333;padding:0 0 .4rem;margin:1rem auto;text ...

Granules India advanced 1.95% to Rs 519 after the company said that its board has approved to acquire 100% stake in Senn Chemicals AG, a Switzerland based company, for a total consideration of Rs 192.

Granules India enters peptide segment and CDMO business by acquiring Senn Chemicals AG: Our Bureau, Bengaluru Monday, February 24, 2025, 12:20 Hrs [IST] Granules India, a generic ...

Granules India has acquired Swiss CDMO company Senn Chemicals AG for Rs 192 crore, expanding its peptide therapeutics market ...

Sanyou Bio’s Intelligent Super-trillion Molecule Discovery Platform consists of ten sub-platforms, encompassing a variety of molecular types. These include super-trillion fully human antibody ...

Generic drugmaker Granules India is foraying into the peptide segment and contract development and manufacturing organisation ...